Intestinal infection triggers mitochondria-mediated α-synuclein pathology: relevance to Parkinson's disease

被引:5
|
作者
Magalhaes, Joao D. [1 ,2 ,3 ]
Candeias, Emanuel [1 ,2 ]
Melo-Marques, Ines [1 ,2 ]
Silva, Diana F. [1 ,2 ]
Esteves, A. Raquel [1 ,2 ]
Empadinhas, Nuno [1 ,2 ]
Cardoso, Sandra Morais [1 ,2 ,4 ]
机构
[1] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal
[2] Univ Coimbra, CIBB Ctr Innovat Biomed & Biotechnol, Coimbra, Portugal
[3] Univ Coimbra, Inst Interdisciplinary Res, Programme Biomed & Expt Biol PDBEB, Coimbra, Portugal
[4] Univ Coimbra, Inst Cellular & Mol Biol, Fac Med, Coimbra, Portugal
关键词
Parkinson's disease; Listeria monocytogenes infection; Innate immunity; Mitochondria; Inflammation; alpha-synuclein; LISTERIA-MONOCYTOGENES; SUBSTANTIA-NIGRA; NERVOUS-SYSTEM; NEURONS; MODEL; EXCITABILITY; IMPAIRMENT; MONOCYTES; TOXINS;
D O I
10.1007/s00018-023-04819-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) is a multifactorial neurodegenerative disease characterized by the loss of dopaminergic neurons in the midbrain. In the prodromal phase several autonomic symptoms including orthostatic hypotension and constipation are correlated with increased a-synuclein pathology in peripheral tissues. It is currently accepted that some idiopathic PD cases may start in the gut (body-first PD) with accumulation of pathological a-synuclein in enteric neurons that may subsequently propagate caudo-rostrally to the central nervous system. In addition to the already-established regulation of synaptic vesicle trafficking, a-synuclein also seems to play a role in neuronal innate immunity after infection. Our goal was to understand if seeding the gut with the foodborne pathogen Listeria monocytogenes by oral gavage would impact gut immunity and eventually the central nervous system. Our results demonstrate that L. monocytogenes infection induced oligomerization of a-synuclein in the ileum, along with a pronounced pro-inflammatory local and systemic response that ultimately culminated in neuronal mitochondria dysfunction. We propose that, having evolved from ancestral endosymbiotic bacteria, mitochondria may be directly targeted by virulence factors of intracellular pathogens, and that mitochondrial dysfunction and fragmentation resulting also from the activation of the innate immune system at the gut level, trigger innate immune responses in midbrain neurons, which include a-synuclein oligomerization and neuroinflammation, all of which hallmarks of PD.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Intestinal infection triggers mitochondria-mediated α-synuclein pathology: relevance to Parkinson’s disease
    João D. Magalhães
    Emanuel Candeias
    Inês Melo-Marques
    Diana F. Silva
    A. Raquel Esteves
    Nuno Empadinhas
    Sandra Morais Cardoso
    Cellular and Molecular Life Sciences, 2023, 80
  • [2] Mitochondria-mediated damage to dopaminergic neurons in Parkinson's disease
    Liu, Xiao-Liang
    Wang, Ying-Di
    Yu, Xiu-Ming
    Li, Da-Wei
    Li, Guang-Ren
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (02) : 615 - 623
  • [3] Pathophysiology of Parkinson's disease: Mitochondria, alpha-synuclein and much more ...
    Rouaud, T.
    Corbille, A-G
    Leclair-Visonneau, L.
    de Lataillade, A. de Guilhem
    Lionnet, A.
    Preterre, C.
    Damier, P.
    Derkinderen, P.
    REVUE NEUROLOGIQUE, 2021, 177 (03) : 260 - 271
  • [4] α-Synuclein pathology in the neostriatum in Parkinson's disease
    Mori, Fumiaki
    Tanji, Kunikazu
    Zhang, Haixin
    Kakita, Akiyoshi
    Takahashi, Hitoshi
    Wakabayashi, Koichi
    ACTA NEUROPATHOLOGICA, 2008, 115 (04) : 453 - 459
  • [5] The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease
    Garg, Pretty
    Maass, Fabian
    Sundaram, Sivaraj M.
    Mollenhauer, Brit
    Mahajani, Sameehan
    van Riesen, Christoph
    Kuegler, Sebastian
    Baehr, Mathias
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2022, 121
  • [6] The Discovery of α-Synuclein in Lewy Pathology of Parkinson's Disease: The Inspiration of a Revolution
    Visanji, Naomi P.
    Kovacs, Gabor G.
    Lang, Anthony E.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2021, 8 (08): : 1189 - 1193
  • [7] Silica Nanoparticles Promote α-Synuclein Aggregation and Parkinson's Disease Pathology
    Yuan, Xin
    Yang, Yingxu
    Xia, Danhao
    Meng, Lanxia
    He, Mingyang
    Liu, Chaoyang
    Zhang, Zhentao
    FRONTIERS IN NEUROSCIENCE, 2022, 15
  • [8] Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson's Disease
    Fitzgerald, Emily
    Murphy, Sarah
    Martinson, Holly A.
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [9] Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson's disease
    Naoi, Makoto
    Maruyama, Wakako
    Shamoto-Nagai, Masayo
    Riederer, Peter
    JOURNAL OF NEURAL TRANSMISSION, 2024, 131 (06) : 639 - 661
  • [10] TFE3-mediated neuroprotection: Clearance of aggregated a-synuclein and accumulated mitochondria in the AAV-a-synuclein model of Parkinson's disease
    He, Xin
    Chen, Mulan
    Fan, Yepeng
    Wu, Bin
    Dong, Zhifang
    GENES & DISEASES, 2025, 12 (02)